Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

35,766 public trials 5,053 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

A Study of ARV-393 in Relapsed/Refractory Non-Hodgkin Lymphoma.

NCT06393738

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +15 more
Locations
  • Clinical Trial Site New Haven, Connecticut, United States
  • Clinical Trial Site Detroit, Michigan, United States
  • Clinical Trial Site New Brunswick, New Jersey, United States
  • Clinical Trial Site New York, United States
View all 19 locations
View Trial Details
Recruiting

A Study to Investigate Efficacy, Safety and Tolerability of Barzolvolimab Versus Placebo in Adults With Cold Induced Urticaria and Symptomatic Dermographism Inadequately Controlled by H1-antihistamines (EMBARQ - ColdU and SD)

NCT07266402

Conditions
Chronic Disease, Chronic Inducible Urticaria, Chronic Urticaria, +14 more
Locations
  • Cahaba Dermatology & Skin Health Center, LLC Birmingham, Alabama, United States
  • One of a Kind Clinical Research Center, LLC Scottsdale, Arizona, United States
  • Kern Research, Inc. Bakersfield, California, United States
  • One of a Kind Clinical Research Center Napa, California, United States
View all 72 locations
View Trial Details
Recruiting

RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus

NCT06121297

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +12 more
Locations
  • University of California Irvine Orange, California, United States
  • UC Davis Health Sacramento, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Florida Health Gainesville, Florida, United States
View all 23 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

NCT06973187

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +15 more
Locations
  • University of Alabama At Birmingham Hospital Birmingham, Alabama, United States
  • Mayo Clinic Phoenix Phoenix, Arizona, United States
  • Kaiser Permanente Southern California Irvine, California, United States
  • University of California San Diego (Ucsd) Moores Cancer Center La Jolla, California, United States
View all 209 locations
View Trial Details
Recruiting

A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

NCT06290141

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Chronic Disease, +12 more
Locations
  • Alabama Neurology Associates- Site Number : 8400019 Homewood, Alabama, United States
  • Honor Health Scottsdale Osborn Medical Center- Site Number : 8400014 Scottsdale, Arizona, United States
  • Keck School of Medicine of University of Southern California- Site Number : 8400002 Los Angeles, California, United States
  • University of California Irvine Medical Center- Site Number : 8400007 Orange, California, United States
View all 135 locations
View Trial Details
Recruiting

A Study of ARC-02 in B-cell NHL

NCT07691606

Conditions
B-cell Non Hodgkin Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +21 more
Locations
  • Start Cala Los Angeles, California, United States
  • Norton Cancer Institute Louisville, Kentucky, United States
  • NYU Langone New York, United States
  • Levine Cancer Institute Charlotte, North Carolina, United States
View all 29 locations
View Trial Details
Recruiting

Testing Teclistamab (TECVAYLI) in Combination With Iberdomide for Relapsed or Refractory Multiple Myeloma

NCT06465316

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • Smilow Cancer Hospital-Derby Care Center Derby, Connecticut, United States
  • Smilow Cancer Hospital Care Center - Guilford Guilford, Connecticut, United States
  • Yale University New Haven, Connecticut, United States
View all 14 locations
View Trial Details

Related conditions